Abstract
Metastasis is the major killer of cancer patients. Although increased understanding of the metastatic process was achieved in recent years, the mechanisms underlying the progression of cancer cells to form site-specific metastasis are still awaiting complete elucidation. The current consensus is that circulating tumor cells disseminate into future metastatic sites and that these disseminated tumor cells form micrometastasis in these sites. The micrometastases remain in a state of dormancy in these sites until “awakened” to progress towards overt metastases. Whereas the evidence implicating chemokine–chemokine receptor interactions as the mechanism responsible for the targeted migration of tumor cells to future metastatic sites is quite strong, the mechanisms that maintain dormancy of disseminated tumor cells and the mechanisms that awaken these dormant micrometastases, driving their progression towards frank metastasis, are still obscure. It is clear, however, that the metastatic microenvironment plays a major role in these events. Three topics are discussed in this review: Mechanisms that are involved in the targeted migration of tumor cells to future metastatic sites; Specific molecular signatures expressed by metastases and micrometastases and interactions between metastatic and micrometastatic cells with the metastatic microenvironment. In reviewing these topics we focused on studies performed in our lab with neuroblatoma lung and melanoma brain metastasis.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- TME:
-
Tumor microenvironment
- CAF:
-
cancer-associated fibroblast
- CXCL:
-
chemokine (C-X-C motif) ligand
- SDF:
-
Stromal cell-derived actor
- CCL:
-
Chemokine (C–C motif) ligand
- TNF:
-
Tumor necrosis factor
- MCP:
-
Monocyte chemotactic protein
- CXCR:
-
Chemokine (C-X-C motif) receptor
- IFN:
-
Interferon
- TEM:
-
Transendothelial migration
- CCR:
-
Chemokine (C–C) motif receptor
- CTC:
-
Circulating tumor cells
- DTC:
-
Disseminated tumor cells
- PHOX:
-
Paired-like homeobox
- MMP:
-
Matrix metalloproteinase
- ERK:
-
Extracellular Signal-Regulated Kinase
- PCR:
-
Polymerase chain reaction
References
Achyut BR, Yang L (2011) Transforming growth factor-beta in the gastrointestinal and hepatic tumor microenvironment. Gastroenterology 141:1167–1178
Adler AS, Chang HY (2006) From description to causality: mechanisms of gene expression signatures in cancer. Cell Cycle 5:1148–1151
Agostini C, Calabrese F, Rea F, Facco M, Tosoni A, Loy M et al (2001) Cxcr3 and its ligand CXCL10 are expressed by inflammatory cells infiltrating lung allografts and mediate chemotaxis of T cells at sites of rejection. Am J Pathol 158:1703–1711
Albini A, Mirisola V, Pfeffer U (2008) Metastasis signatures: genes regulating tumor-microenvironment interactions predict metastatic behavior. Cancer Metastasis Rev 27:75–83
Alix-Panabieres C, Riethdorf S, Pantel K (2008) Circulating tumor cells and bone marrow micrometastasis. Clin Cancer Res 14:5013–5021
Allen M, Louise Jones J (2011) Jekyll and Hyde: the role of the microenvironment on the progression of cancer. J Pathol 223:162–176
Bafaloukos D, Gogas H (2004) The treatment of brain metastases in melanoma patients. Cancer Treat Rev 30:515–520
Balic M, Williams A, Dandachi N, Cote RJ (2010) Micrometastasis: detection methods and clinical importance. Cancer Biomark 9:397–419
Bar-Eli M (1999) Role of interleukin-8 in tumor growth and metastasis of human melanoma. Pathobiology 67:12–18
Ben-Baruch A (2003a) Host microenvironment in breast cancer development: inflammatory cells, cytokines and chemokines in breast cancer progression: reciprocal tumor-microenvironment interactions. Breast Cancer Res: BCR 5:31–36
Ben-Baruch A (2003b) Host microenvironment in breast cancer development: inflammatory cells, cytokines and chemokines in breast cancer progression: reciprocal tumor-microenvironment interactions. Breast Cancer Res 5:31–36
Ben-Baruch A (2008) Organ selectivity in metastasis: regulation by chemokines and their receptors. Clin Exp Metastasis 25:345–356
Bidard FC, Pierga JY, Vincent-Salomon A, Poupon MF (2008) A “class action” against the microenvironment: do cancer cells cooperate in metastasis? Cancer Metastasis Rev 27:5–10
Bissell MJ, Hines WC (2011) Why don’t we get more cancer? A proposed role of the microenvironment in restraining cancer progression. Nat Med 17:320–329
Bos PD, Zhang XH, Nadal C, Shu W, Gomis RR, Nguyen DX et al (2009) Genes that mediate breast cancer metastasis to the brain. Nature 459:1005–1009
Braun S, Naume B (2005) Circulating and disseminated tumor cells. J Clin Oncol 23:1623–1626
Brodeur GM, Castleberry RP (1997) Neuroblastoma. In: Pizzo PA, Poplack DG (eds) Principles and practice of pediatric oncology, 3rd edn. Lippincott-Raven Publishers, Philadelphia, pp 761–783
Budhu AS, Zipser B, Forgues M, Ye QH, Sun Z, Wang XW (2005) The molecular signature of metastases of human hepatocellular carcinoma. Oncology 69(Suppl 1):23–27
Burger JA, Kipps TJ (2006) CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment. Blood 107:1761–1767
Cairns RA, Khokha R, Hill RP (2003) Molecular mechanisms of tumor invasion and metastasis: an integrated view. Curr Mol Med 3:659–671
Chaffer CL, Weinberg RA (2011) A perspective on cancer cell metastasis. Science 331:1559–1564
Chakraborty K, Bose A, Pal S, Sarkar K, Goswami S, Ghosh D et al (2008) Neem leaf glycoprotein restores the impaired chemotactic activity of peripheral blood mononuclear cells from head and neck squamous cell carcinoma patients by maintaining CXCR3/CXCL10 balance. Int Immunopharmacol 8:330–340
Chambers AF, Groom AC, MacDonald IC (2002) Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer 2:563–572
Chaput N, Conforti R, Viaud S, Spatz A, Zitvogel L (2008) The Janus face of dendritic cells in cancer. Oncogene 27:5920–5931
Cirri P, Chiarugi P (2012) Cancer-associated-fibroblasts and tumour cells: a diabolic liaison driving cancer progression. Cancer Metastasis Rev 31:195–208
Coghlin C, Murray GI (2010) Current and emerging concepts in tumour metastasis. J Pathol 222:1–15
Cote RJ, Rosen PP, Lesser ML, Old LJ, Osborne MP (1991) Prediction of early relapse in patients with operable breast cancer by detection of occult bone marrow micrometastases. J Clin Oncol 9:1749–1756
Cowie F, Corbett R, Pinkerton CR (1997) Lung involvement in neuroblastoma: incidence and characteristics. Med Pediatr Oncol 28:429–432
Croci DO, Zacarias Fluck MF, Croci DO, Rico MJ, Matar P, Rabinovich GA, Scharovsky OG (2007) Dynamic cross-talk between tumor and immune cells in orchestrating the immunosuppressive network at the tumor microenvironment. Cancer Immunol Immunother 56:1687–1700
Cuiffo BG, Karnoub AE (2012) Mesenchymal stem cells in tumor development: emerging roles and concepts. Cell Adhes Migr 6:220–230
Cunha GR, Hayward SW, Wang YZ (2002) Role of stroma in carcinogenesis of the prostate. Differentiation; Res Biol Divers 70:473–485
Cunha GR, Hayward SW, Wang YZ, Ricke WA (2003) Role of the stromal microenvironment in carcinogenesis of the prostate. Int j Cancer J Int du Cancer 107:1–10
Dai CY, Haqq CM, Puzas JE (2006) Molecular correlates of site-specific metastasis. Semin Radiat Oncol 16:102–110
Dearnaley DP, Sloane JP, Ormerod MG, Steele K, Coombes RC, Clink HM et al (1981) Increased detection of mammary carcinoma cells in marrow smears using antisera to epithelial membrane antigen. Br J Cancer 44:85–90
Denkins Y, Reiland J, Roy M, Sinnappah-Kang ND, Galjour J, Murry BP et al (2004) Brain metastases in melanoma: roles of neurotrophins. Neuro Oncol 6:154–165
DiMeo TA, Kuperwasser C (2006) The evolving paradigm of tissue-specific metastasis. Breast Cancer Res 8:301
Edry Botzer L, Maman S, Sagi-Assif O, Meshel T, Nevo I, Bauerle T et al (2011) Lung-residing metastatic and dormant neuroblastoma cells. Am J Pathol 179:524–536
Egeblad M, Nakasone ES, Werb Z (2010) Tumors as organs: complex tissues that interface with the entire organism. Dev Cell 18:884–901
Eshel R, Neumark E, Sagi-Assif O, Witz IP (2002) Receptors involved in microenvironment-driven molecular evolution of cancer cells. Semin Cancer Biol 12:139–147
Fidler IJ (2001) Seed and soil revisited: contribution of the organ microenvironment to cancer metastasis. Surgical oncology clinics of North America 10:257–69, vii-viiii
Fidler IJ (2002) Critical determinants of metastasis. Semin Cancer Biol 12:89–96
Fidler IJ (2011) The role of the organ microenvironment in brain metastasis. Semin Cancer Biol 21:107–112
Fingleton B (2007) Molecular targets in metastasis: lessons from genomic approaches. Cancer Genomics Proteomics 4:211–221
Flaberg E, Markasz L, Petranyi G, Stuber G, Dicso F, Alchihabi N et al (2011) High-throughput live-cell imaging reveals differential inhibition of tumor cell proliferation by human fibroblasts. Int J Cancer J Int du Cancer 128:2793–2802
Flaberg E, Guven H, Savchenko A, Pavlova T, Kashuba V, Szekely L (2012) et al. The architecture of fibroblast monolayers of different origin differentially influences tumor cell growth. Int J Cancer J Int du Cancer 131:2274–2283
Friedl P, Alexander S (2011) Cancer invasion and the microenvironment: plasticity and reciprocity. Cell 147:992–1009
Fulton AM (2009) The chemokine receptors CXCR4 and CXCR3 in cancer. Curr Oncol Rep 11:125–131
Geminder H, Sagi-Assif O, Goldberg L, Meshel T, Rechavi G, Witz IP et al (2001) A possible role for CXCR4 and its ligand, the CXC chemokine stromal cell-derived factor-1, in the development of bone marrow metastases in neuroblastoma. J Immunol 167:4747–4757
Glinsky GV (2006) Genomic models of metastatic cancer: functional analysis of death-from-cancer signature genes reveals aneuploid, anoikis-resistant, metastasis-enabling phenotype with altered cell cycle control and activated Polycomb Group (PcG) protein chromatin silencing pathway. Cell Cycle 5:1208–1216
Goetz JG (2012) Tumor microenvironment indoctrination: An emerging hallmark of cancer. Cell Adhes Migr 6:190–192
Goss PE, Chambers AF (2010) Does tumour dormancy offer a therapeutic target? Nat Rev Cancer 10:871–877
Gupta GP, Massague J (2006) Cancer metastasis: building a framework. Cell 127:679–695
Gupta PB, Mani S, Yang J, Hartwell K, Weinberg RA (2005) The evolving portrait of cancer metastasis. Cold Spring Harb Symp Quant Biol 70:291–297
Hardy KM, Booth BW, Hendrix MJ, Salomon DS, Strizzi L (2010) ErbB/EGF signaling and EMT in mammary development and breast cancer. J Mammary Gland Biol Neoplasia 15:191–199
Harlozinska A (2005) Progress in molecular mechanisms of tumor metastasis and angiogenesis. Anticancer Res 25:3327–3333
Hart IR (1982) ‘Seed and soil’ revisited: mechanisms of site-specific metastasis. Cancer Metastasis Rev 1:5–16
Hart IR, Fidler IJ (1980) Role of organ selectivity in the determination of metastatic patterns of B16 melanoma. Cancer Res 40:2281–2287
Hart IR, Talmadge JE, Fidler IJ (1981) Metastatic behavior of a murine reticulum cell sarcoma exhibiting organ-specific growth. Cancer Res 41:1281–1287
Hedley BD, Chambers AF (2009) Tumor dormancy and metastasis. Adv Cancer Res 102:67–101
Hendrix MJ, Seftor EA, Kirschmann DA, Quaranta V, Seftor RE (2003) Remodeling of the microenvironment by aggressive melanoma tumor cells. Ann NY Acad Sci 995:151–161
Hu M, Polyak K (2008) Microenvironmental regulation of cancer development. Curr Opin Genet Dev 18:27–34
Hunter KW (2004) Host genetics and tumour metastasis. Br J Cancer 90:752–755
Izraely S, Klein A, Sagi-Assif O, Meshel T, Tsarfaty G, Hoon DS et al (2010) Chemokine-chemokine receptor axes in melanoma brain metastasis. Immunol Lett 130:107–114
Izraely S, Sagi-Assif O, Klein A, Meshel T, Tsarfaty G, Pasmanik-Chor M et al (2012) The metastatic microenvironment: brain-residing melanoma metastasis and dormant micrometastasis. Int J Cancer J Int du Cancer 131:1071–1082
Joyce JA, Pollard JW (2009) Microenvironmental regulation of metastasis. Nat Rev Cancer 9:239–252
Jung YD, Ahmad SA, Liu W, Reinmuth N, Parikh A, Stoeltzing O et al (2002) The role of the microenvironment and intercellular cross-talk in tumor angiogenesis. Semin Cancer Biol 12:105–112
Kakinuma T, Hwang ST (2006) Chemokines, chemokine receptors, and cancer metastasis. J Leukoc Biol 79:639–651
Kammen BF, Matthay KK, Pacharn P, Gerbing R, Brasch RC, Gooding CA (2001) Pulmonary metastases at diagnosis of neuroblastoma in pediatric patients: CT findings and prognosis. AJR Am J Roentgenol 176:755–759
Kang Y, Siegel PM, Shu W, Drobnjak M, Kakonen SM, Cordon-Cardo C et al (2003) A multigenic program mediating breast cancer metastasis to bone. Cancer Cell 3:537–549
Kaplan RN, Rafii S, Lyden D (2006) Preparing the “soil”: the premetastatic niche. Cancer Res 66:11089–11093
Khoo JJ, Forster S, Mansell A (2011) Toll-like receptors as interferon-regulated genes and their role in disease. J Interferon Cytokine Res: The Official J Int Soc Interferon Cytokine Res 31:13–25
Kim RS, Avivar-Valderas A, Estrada Y, Bragado P, Sosa MS, Aguirre-Ghiso JA et al (2012) Dormancy signatures and metastasis in estrogen receptor positive and negative breast cancer. PLoS ONE 7:e35569
Klebanoff CA, Acquavella N, Yu Z, Restifo NP (2011) Therapeutic cancer vaccines: are we there yet? Immunol Rev 239:27–44
Klein G, Imreh S, Zabarovsky ER (2007) Why do we not all die of cancer at an early age? Adv Cancer Res 98:1–16
Klein A, Sagi-Assif O, Izraely S, Meshel T, Pasmanik-Chor M, Nahmias C, et al. (2012) The metastatic microenvironment: brain-derived soluble factors alter the malignant phenotype of cutaneous and brain-metastasizing melanoma cells. Int J Cancer 131:2509–2518
Koh BI, Kang Y (2012) The pro-metastatic role of bone marrow-derived cells: a focus on MSCs and regulatory T cells. EMBO Rep 13:412–422
Kopfstein L, Christofori G (2006) Metastasis: cell-autonomous mechanisms versus contributions by the tumor microenvironment. Cell Mol Life Sci: CMLS 63:449–468
Korkaya H, Liu S, Wicha MS (2011) Breast cancer stem cells, cytokine networks, and the tumor microenvironment. J Clin Investig 121:3804–3809
Krishnan V, Stadick N, Clark R, Bainer R, Veneris JT, Khan S, et al. (2012) Using MKK4’s metastasis suppressor function to identify and dissect cancer cell-microenvironment interactions during metastatic colonization. Cancer Metastasis Rev 31:605–613
Kumar S, Weaver VM (2009) Mechanics, malignancy, and metastasis: the force journey of a tumor cell. Cancer Metastasis Rev 28:113–127
Kuo TH, Kubota T, Watanabe M, Furukawa T, Teramoto T, Ishibiki K et al (1995) Liver colonization competence governs colon cancer metastasis. Proc Natl Acad Sci USA 92:12085–12089
Langley RR, Fidler IJ (2007) Tumor cell-organ microenvironment interactions in the pathogenesis of cancer metastasis. Endocr Rev 28:297–321
Langley RR, Fidler IJ (2011) The seed and soil hypothesis revisited–the role of tumor-stroma interactions in metastasis to different organs. Int J Cancer J Int du Cancer 128:2527–2535
Lawrence JA, Steeg PS (1996) Mechanisms of tumor invasion and metastasis. World J Urol 14:124–130
Lin HJ, Zuo T, Chao JR, Peng Z, Asamoto LK, Yamashita SS et al (2009) Seed in soil, with an epigenetic view. Biochim Biophys Acta 1790:920–924
Lindemann F, Schlimok G, Dirschedl P, Witte J, Riethmuller G (1992) Prognostic significance of micrometastatic tumour cells in bone marrow of colorectal cancer patients. Lancet 340:685–689
Liotta LA, Kohn EC (2001) The microenvironment of the tumour-host interface. Nature 411:375–379
Lorusso G, Ruegg C (2012) New insights into the mechanisms of organ-specific breast cancer metastasis. Semin Cancer Biol 22:226–233
Lukanidin E, Sleeman JP (2012) Building the niche: the role of the S100 proteins in metastatic growth. Semin Cancer Biol 22:216–225
Lynch CC, Matrisian LM (2002) Matrix metalloproteinases in tumor-host cell communication. Differ; Res Biol Divers 70:561–573
Mantovani A, Bottazzi B, Colotta F, Sozzani S, Ruco L (1992) The origin and function of tumor-associated macrophages. Immunol Today 13:265–270
Mantovani A, Allavena P, Sica A (2004) Tumour-associated macrophages as a prototypic type II polarised phagocyte population: role in tumour progression. Eur J Cancer 40:1660–1667
Marchesi F, Locatelli M, Solinas G, Erreni M, Allavena P, Mantovani A (2010) Role of CX3CR1/CX3CL1 axis in primary and secondary involvement of the nervous system by cancer. J Neuroimmunol 224:39–44
Maru SV, Holloway KA, Flynn G, Lancashire CL, Loughlin AJ, Male DK et al (2008) Chemokine production and chemokine receptor expression by human glioma cells: role of CXCL10 in tumour cell proliferation. J Neuroimmunol 199:35–45
Mathot L, Stenninger J (2012) Behavior of seeds and soil in the mechanism of metastasis: a deeper understanding. Cancer Sci 103:626–631
Matsumiya T, Stafforini DM (2010) Function and regulation of retinoic acid-inducible gene-I. Crit Rev Immunol 30:489–513
McCawley LJ, Matrisian LM (2001) Tumor progression: defining the soil round the tumor seed. Curr Biol: CB 11:R25–R27
Mehlen P, Puisieux A (2006) Metastasis: a question of life or death. Nat Rev Cancer 6:449–458
Meng S, Tripathy D, Frenkel EP, Shete S, Naftalis EZ, Huth JF et al (2004) Circulating tumor cells in patients with breast cancer dormancy. Clin Cancer Res 10:8152–8162
Meyer T, Hart IR (1998) Mechanisms of tumour metastasis. Eur J Cancer 34:214–221
Minn AJ, Gupta GP, Siegel PM, Bos PD, Shu W, Giri DD et al (2005a) Genes that mediate breast cancer metastasis to lung. Nature 436:518–524
Minn AJ, Kang Y, Serganova I, Gupta GP, Giri DD, Doubrovin M et al (2005b) Distinct organ-specific metastatic potential of individual breast cancer cells and primary tumors. J Clin Invest 115:44–55
Modak S, Cheung NK (2010) Neuroblastoma: therapeutic strategies for a clinical enigma. Cancer Treat Rev 36:307–317
Mueller MM, Fusenig NE (2002) Tumor-stroma interactions directing phenotype and progression of epithelial skin tumor cells. Differe; Res Biolo Divers 70:486–497
Mullassery D, Dominici C, Jesudason EC, McDowell HP, Losty PD (2009) Neuroblastoma: contemporary management. Archives Dis Childhood Educ Pract Ed 94:177–185
Muller A, Homey B, Soto H, Ge N, Catron D, Buchanan ME et al (2001) Involvement of chemokine receptors in breast cancer metastasis. Nature 410:50–56
Nadal C, Maurel J, Gascon P (2007) Is there a genetic signature for liver metastasis in colorectal cancer? World J Gastroenterol: WJG 13:5832–5844
Navarini-Meury AA, Conrad C (2009) Melanoma and innate immunity–aActive inflammation or just erroneous attraction? Melanoma as the source of leukocyte-attracting chemokines. Semin Cancer Biol 19:84–91
Neumark E, Sagi-Assif O, Shalmon B, Ben-Baruch A, Witz IP (2003) Progression of mouse mammary tumors: MCP-1-TNFalpha cross-regulatory pathway and clonal expression of promalignancy and antimalignancy factors. Int J Cancer 106:879–886
Nevo I, Sagi-Assif O, Meshel T, Geminder H, Goldberg-Bittman L, Ben-Menachem S et al (2004) The tumor microenvironment: CXCR4 is associated with distinct protein expression patterns in neuroblastoma cells. Immunol Lett 92:163–169
Nevo I, Sagi-Assif O, Edry Botzer L, Amar D, Maman S, Kariv N et al (2008) Generation and characterization of novel local and metastatic human neuroblastoma variants. Neoplasia 10:816–827
Nevo I, Sagi-Assif O, Meshel T, Ben-Baruch A, Johrer K, Greil R et al (2009) The involvement of the fractalkine receptor in the transmigration of neuroblastoma cells through bone-marrow endothelial cells. Cancer Lett 273:127–139
Nevo I, Oberthuer A, Botzer E, Sagi-Assif O, Maman S, Pasmanik-Chor M et al (2010) Gene-expression-based analysis of local and metastatic neuroblastoma variants reveals a set of genes associated with tumor progression in neuroblastoma patients. Int J Cancer 126:1570–1581
Nguyen TH (2004) Mechanisms of metastasis. Clin Dermatol 22:209–216
Nguyen DX, Massague J (2007) Genetic determinants of cancer metastasis. Nat Rev Genet 8:341–352
Nicolson GL (1988) Organ specificity of tumor metastasis: role of preferential adhesion, invasion and growth of malignant cells at specific secondary sites. Cancer Metastasis Rev 7:143–188
Nishimori H, Ehata S, Suzuki HI, Katsuno Y, Miyazono K (2012) Prostate cancer cells and bone stromal cells mutually interact with each other through bone morphogenetic protein-mediated signals. J Biol Chem 287:20037–20046
Oberthuer A, Berthold F, Warnat P, Hero B, Kahlert Y, Spitz R et al (2006) Customized oligonucleotide microarray gene expression-based classification of neuroblastoma patients outperforms current clinical risk stratification. J Clin Oncol 24:5070–5078
Onuigbo WI (1975) Human model for studying seed-soil factors in blood-borne metastasis. Arch Pathol 99:342–343
Orimo A, Gupta PB, Sgroi DC, Arenzana-Seisdedos F, Delaunay T, Naeem R et al (2005) Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 121:335–348
Paget S (1889) The distribution of secondary growths in cancer of the breast. The Lancet 133:571–573
Palmieri D, Smith QR, Lockman PR, Bronder J, Gril B, Chambers AF et al (2006) Brain metastases of breast cancer. Breast Dis 26:139–147
Palmieri D, Chambers AF, Felding-Habermann B, Huang S, Steeg PS (2007) The biology of metastasis to a sanctuary site. Clin Cancer Res 13:1656–1662
Pantel K, Brakenhoff RH (2004) Dissecting the metastatic cascade. Nat Rev Cancer 4:448–456
Pantel K, Izbicki JR, Angstwurm M, Braun S, Passlick B, Karg O et al (1993a) Immunocytological detection of bone marrow micrometastasis in operable non-small cell lung cancer. Cancer Res 53:1027–1031
Pantel K, Braun S, Schlimok G, Riethmuller G (1993b) Micrometastatic tumour cells in bone marrow in colorectal cancer. Lancet 341:501
Park CC, Bissell MJ, Barcellos-Hoff MH (2000) The influence of the microenvironment on the malignant phenotype. Mol Med Today 6:324–329
Pass HI (2002) Biology of metastatic disease. Semin Thorac Cardiovasc Surg 14:10–17
Pauli BU, Lee CL (1988) Organ preference of metastasis. The role of organ-specifically modulated endothelial cells. Lab Invest; J Tech Methods Pathol 58:379–387
Pauli BU, Augustin-Voss HG, Augustin-Voss HG, el-Sabban ME, Johnson RC, Hammer DA (1990) Organ-preference of metastasis. The role of endothelial cell adhesion molecules. Cancer Metastasis Rev 9:175–189
Peinado H, Lavotshkin S, Lyden D (2011) The secreted factors responsible for pre-metastatic niche formation: old sayings and new thoughts. Semin Cancer Biol 21:139–146
Pratap J, Lian JB, Stein GS (2011) Metastatic bone disease: role of transcription factors and future targets. Bone 48:30–36
Psaila B, Kaplan RN, Port ER, Lyden D (2006) Priming the ‘soil’ for breast cancer metastasis: the pre-metastatic niche. Breast Dis 26:65–74
Radinsky R (1995) Modulation of tumor cell gene expression and phenotype by the organ-specific metastatic environment. Cancer Metastasis Rev 14:323–338
Radinsky R, Fidler IJ (1992) Regulation of tumor cell growth at organ-specific metastases. In Vivo 6:325–331
Reddy BY, Lim PK, Silverio K, Patel SA, Won BW, Rameshwar P (2012) The microenvironmental effect in the progression, metastasis, and dormancy of breast cancer: a model system within bone marrow. Int J Breast Cancer 2012:721659
Richmond A, Yang J, Su Y (2009) The good and the bad of chemokines/chemokine receptors in melanoma. Pigment Cell Melanoma Res 22:175–186
Riethdorf S, Wikman H, Pantel K (2008) Review: Biological relevance of disseminated tumor cells in cancer patients. Int J Cancer 123:1991–2006
Riethmuller G, Johnson JP (1992) Monoclonal antibodies in the detection and therapy of micrometastatic epithelial cancers. Curr Opin Immunol 4:647–655
Ring BZ, Ross DT (2005) Predicting the sites of metastases. Genome Biol 6:241
Ringel MD (2011) Metastatic dormancy and progression in thyroid cancer: targeting cells in the metastatic frontier. Thyroid 21:487–492
Romsdahl MM, Potter JF, Malmgren RA, Chu EW, Brindley CO, Smith RR (1960) A clinical study of circulating tumor cells in malignant melanoma. Surg Gynecol Obstet 111:675–681
Rowley D, Barron DA (2012) The reactive stroma microenvironment and prostate cancer progression. Endocrine-related cancer 19:R187–204
Rubin H (2001) Selected cell and selective microenvironment in neoplastic development. Cancer Res 61:799–807
Ruiz P, Gunthert U (1996) The cellular basis of metastasis. World J Urol 14:141–150
Russell HV, Hicks J, Okcu MF, Nuchtern JG (2004) CXCR4 expression in neuroblastoma primary tumors is associated with clinical presentation of bone and bone marrow metastases. J Pediatr Surg 39:1506–1511
Sabbah M, Emami S, Redeuilh G, Julien S, Prevost G, Zimber A et al (2008) Molecular signature and therapeutic perspective of the epithelial-to-mesenchymal transitions in epithelial cancers. Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy 11:123–151
Sapoznik S, Ortenberg R, Galore-Haskel G, Kozlovski S, Levy D, Avivi C, et al. (2012) CXCR1 as a novel target for directing reactive T cells toward melanoma: implications for adoptive cell transfer immunotherapy. Cancer Immunol Immunother 61:1833–1847
Sarasin A, Kauffmann A (2008) Overexpression of DNA repair genes is associated with metastasis: a new hypothesis. Mutat Res 659:49–55
Schlimok G, Riethmuller G (1990) Detection, characterization and tumorigenicity of disseminated tumor cells in human bone marrow. Semin Cancer Biol 1:207–215
Schlimok G, Gottlinger H, Funke I, Swierkot S, Hauser H, Riethmuller G (1986) In vivo and in vitro labelling of epithelial tumor cells with anti 17–1A monoclonal antibodies in bone marrow of cancer patients. Hybridoma 5(Suppl 1):S163–S170
Schlimok G, Funke I, Bock B, Schweiberer B, Witte J, Riethmuller G (1990) Epithelial tumor cells in bone marrow of patients with colorectal cancer: immunocytochemical detection, phenotypic characterization, and prognostic significance. J Clin Oncol 8:831–837
Schlimok G, Funke I, Pantel K, Strobel F, Lindemann F, Witte J et al (1991) Micrometastatic tumour cells in bone marrow of patients with gastric cancer: methodological aspects of detection and prognostic significance. Eur J Cancer 27:1461–1465
Schmid MC, Varner JA (2010) Myeloid cells in the tumor microenvironment: modulation of tumor angiogenesis and tumor inflammation. J Oncol 2010:201026
Shibue T, Weinberg RA (2011) Metastatic colonization: settlement, adaptation and propagation of tumor cells in a foreign tissue environment. Semin Cancer Biol 21:99–106
Sleeman JP, Christofori G, Fodde R, Collard JG, Berx G, Decraene C et al (2012) Concepts of metastasis in flux: the stromal progression model. Semin Cancer Biol 22:174–186
Soffietti R, Ruda R, Mutani R (2002) Management of brain metastases. J Neurol 249:1357–1369
Somasundaram R, Herlyn D (2009) Chemokines and the microenvironment in neuroectodermal tumor-host interaction. Semin Cancer Biol 19:92–96
Soria G, Yaal-Hahoshen N, Azenshtein E, Shina S, Leider-Trejo L, Ryvo L et al (2008) Concomitant expression of the chemokines RANTES and MCP-1 in human breast cancer: a basis for tumor-promoting interactions. Cytokine 44:191–200
Soria G, Lebel-Haziv Y, Ehrlich M, Meshel T, Suez A, Avezov E et al (2012) Mechanisms regulating the secretion of the promalignancy chemokine CCL5 by breast tumor cells: CCL5’s 40 s loop and intracellular glycosaminoglycans. Neoplasia 14:1–19
Spano D, Zollo M (2012) Tumor microenvironment: a main actor in the metastasis process. Clin Exp Metastasis 29:381–395
Spano D, Heck C, De Antonellis P, Christofori G, Zollo M (2012) Molecular networks that regulate cancer metastasis. Semin Cancer Biol 22:234–249
St Hill CA (2011) Interactions between endothelial selectins and cancer cells regulate metastasis. Front Biosci: J Virtual Libr 16:3233–3251
Steeg PS (2005) New insights into the tumor metastatic process revealed by gene expression profiling. Am J Pathol 166:1291–1294
Takeuchi H, Kitago M, Hoon DS (2007) Effects of chemokines on tumor metastasis. Cancer Treat Res 135:177–184
Taylor MA, Lee YH, Schiemann WP (2011) Role of TGF-beta and the tumor microenvironment during mammary tumorigenesis. Gene Expr 15:117–132
Timar J, Gyorffy B, Raso E (2010) Gene signature of the metastatic potential of cutaneous melanoma: too much for too little? Clin Exp Metastasis 27:371–387
Tlsty TD (2001) Stromal cells can contribute oncogenic signals. Semin Cancer Biol 11:97–104
Togo S, Shimada H, Kubota T, Moossa AR, Hoffman RM (1995) “Seed” to “soil” is a return trip in metastasis. Anticancer Res 15:791–794
Umansky V, Sevko A (2012) Melanoma-induced immunosuppression and its neutralization. Semin Cancer Biol 22:319–326
Unger M, Weaver VM (2003) The tissue microenvironment as an epigenetic tumor modifier. Methods Mol Biol 223:315–347
Valastyan S, Weinberg RA (2011) Tumor metastasis: molecular insights and evolving paradigms. Cell 147:275–292
van Kempen LC, Rhee JS, Dehne K, Lee J, Edwards DR, Coussens LM (2002) Epithelial carcinogenesis: dynamic interplay between neoplastic cells and their microenvironment. Differ; Res Biol Divers 70:610–623
Vera-Ramirez L, Sanchez-Rovira P, Ramirez-Tortosa CL, Quiles JL, Ramirez-Tortosa MC, Alvarez JC et al (2010) Gene-expression profiles, tumor microenvironment, and cancer stem cells in breast cancer: latest advances towards an integrated approach. Cancer Treat Rev 36:477–484
Wang J, Loberg R, Taichman RS (2006) The pivotal role of CXCL12 (SDF-1)/CXCR4 axis in bone metastasis. Cancer Metastasis Rev 25:573–587
Weil RJ, Palmieri DC, Bronder JL, Stark AM, Steeg PS (2005) Breast cancer metastasis to the central nervous system. American J Pathol 167:913–920
Weinberg RA (1995) Prospects for cancer genetics. Cancer Surv 25:3–12
Weinberg RA (2008) Coevolution in the tumor microenvironment. Nat Genet 40:494–495
Weiss L, Voit A, Lane WW (1984) Metastatic patterns in patients with carcinomas of the lower esophagus and upper rectum. Invasion Metastasis 4:47–60
Weiss L, Harlos JP, Torhorst J, Gunthard B, Hartveit F, Svendsen E et al (1988) Metastatic patterns of renal carcinoma: an analysis of 687 necropsies. J Cancer Res Clin Oncol 114:605–612
Witz IP (2008a) Yin-Yang activities and vicious cycles in the tumor microenvironment. Cancer Res 68:9–13
Witz IP (2008b) Tumor-microenvironment interactions: dangerous liaisons. Adv Cancer Res 100:203–229
Witz IP, Levy-Nissenbaum O (2006) The tumor microenvironment in the post-PAGET era. Cancer Lett 242:1–10
Woo HG, Park ES, Thorgeirsson SS, Kim YJ (2011) Exploring genomic profiles of hepatocellular carcinoma. Mol Carcinog 50:235–243
Yokota J (2000) Tumor progression and metastasis. Carcinogenesis 21:497–503
Yokoyama N, Otani T, Hashidate H, Maeda C, Katada T, Sudo N et al (2012) Real-time detection of hepatic micrometastases from pancreatic cancer by intraoperative fluorescence imaging: preliminary results of a prospective study. Cancer 118:2813–2819
Zhang J, Lu Y, Pienta KJ (2010) Multiple roles of chemokine (C–C motif) ligand 2 in promoting prostate cancer growth. J Natl Cancer Inst 102:522–528
Zigrino P, Loffek S, Mauch C (2005) Tumor-stroma interactions: their role in the control of tumor cell invasion. Biochimie 87:321–328
Zipin-Roitman A, Meshel T, Sagi-Assif O, Shalmon B, Avivi C, Pfeffer RM et al (2007) CXCL10 promotes invasion-related properties in human colorectal carcinoma cells. Cancer Res 67:3396–3405
Zlotnik A, Burkhardt AM, Homey B (2011) Homeostatic chemokine receptors and organ-specific metastasis. Nat Rev Immunol 11:597–606
Acknowledgments
The studies performed in Dr. Witz’s laboratory are generously supported by the following foundations and individuals: The Dr. Miriam and Sheldon G. Adelson Medical Research Foundation (Needham, MA, USA); Bonnie and Steven Stern (New York, NY, USA); The Deutsche Forschungsgemeinschaft (DFG); The Fred August and Adele Wolpers Charitable Fund (Clifton, NJ, USA); the late Natan Blutinger (West Orange, NJ, USA); The Pikovsky Fund (Jerusalem, Israel); and James J. Leibman and Rita S. Leibman Endowment Fund for Cancer Research (New York, NY, USA).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Maman, S., Witz, I.P. (2013). The Metastatic Microenvironment . In: Shurin, M., Umansky, V., Malyguine, A. (eds) The Tumor Immunoenvironment. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-6217-6_2
Download citation
DOI: https://doi.org/10.1007/978-94-007-6217-6_2
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-007-6216-9
Online ISBN: 978-94-007-6217-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)